Trial: 202011117

Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogenic Hematopoietic Cell Transplantation Recipients

Phase

I/II

Principal Investigator

Dubberke, Erik

Disease Site

Bone Marrow Transplant; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov